FDA Drug recall D-1536-2022
Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc
- FDA Drug
- Class II
- terminated
- Published 2022-09-21
On 2022-09-21 the FDA classified a Class II recall of Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc by Lupin Pharmaceuticals, citing presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1536-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-09-13 |
| Published | 2022-09-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03
Reason
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Identifiers
| ndc | 68180-512-02 |
|---|---|
| ndc | 68180-512-30 |
| ndc | 68180-512-09 |
| ndc | 68180-512-01 |
| ndc | 68180-512-03 |
| ndc | 68180-513-30 |
| ndc | 68180-513-03 |
| ndc | 68180-513-01 |
| ndc | 68180-513-09 |
| ndc | 68180-513-02 |
| ndc | 68180-513-05 |
| ndc | 68180-517-03 |
| ndc | 68180-517-01 |
| ndc | 68180-517-30 |
| ndc | 68180-517-09 |
| ndc | 68180-517-04 |
| ndc | 68180-517-02 |
| ndc | 68180-980-03 |
| ndc | 68180-980-30 |
| ndc | 68180-980-01 |
| ndc | 68180-980-09 |
| ndc | 68180-980-05 |
| ndc | 68180-980-02 |
| ndc | 68180-981-01 |
| ndc | 68180-981-03 |
| ndc | 68180-981-30 |
| ndc | 68180-981-09 |
| ndc | 68180-981-02 |
| ndc | 68180-981-05 |
| ndc | 68180-982-01 |
| ndc | 68180-982-02 |
| ndc | 68180-982-30 |
| ndc | 68180-982-03 |
| ndc | 68180-982-09 |
| ndc | 68180-979-01 |
| ndc | 68180-979-03 |
| ndc | 68180-979-30 |
| ndc | 68180-979-09 |
| ndc | 68180-514-01 |
| ndc | 68180-514-02 |
| ndc | 68180-514-03 |
| ndc | 68180-514-09 |
| ndc | 68180-514-30 |
| ndc | 68180-514-05 |
| ndc | 68180-515-01 |
| ndc | 68180-515-02 |
| ndc | 68180-515-03 |
| ndc | 68180-515-09 |
| ndc | 68180-515-30 |
| ndc | 68180-515-05 |
| ndc | 68180-516-01 |
| ndc | 68180-516-02 |
| ndc | 68180-516-03 |
| ndc | 68180-516-09 |
| ndc | 68180-516-30 |
| code_info | Lot # Q201182, exp. date March 2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1536-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.